Sustainability (ESG)

Sustainability

Welcome to the ESG section of our Investor Relations website. At FamiCord AG, we view environmental, social and governance factors as vital to long-term success. Learn more about our efforts to put sustainability and responsible business practices at the center of our corporate identity.

You can find our ESG report below for download or as part of our annual report under the following link

See report

Company Profile

FamiCord AG focuses its business model on the collection, preparation and storage of stem cells from umbilical cord blood, umbilical cord tissue and other postnatal tissues for future use in therapy. This gives parents the opportunity to provide for the health of their families.

1 000 000

Approx. 1 million units of stored biological material

With customers from around 50 countries, FamiCord AG is an internationally active company with a focus on Europe

745

employees

Materiality Assessment

Materiality assessment process
- Conducting the first comprehensive materiality assessment based on CSRD to identify the company’s material sustainability topics
- Analysis of business activities as well as the upstream and downstream value chain
- Identification of impacts, risks and opportunities for the Group
- Discussion, evaluation and validation of the results with the specialist departments, experts and the Management Board
Material topics (according to ESRS):
- Environment (E1 – E5): Climate change mitigation and energy, resource inflows including resource use
- Social (S1): Own workforce: working conditions and data protection, training and skills development
- Social (S4): Consumers and end users: data protection and access to information
- Social (S2 + S3): Affected communities and workers in the supply chain: no material topic
- Governance (G1): Business conduct

ESG HIGHLIGHTS 2023

Okno dialogowe
Environmental

Climate change mitigation and energy

100 % TÜV-certified green energy from renewable sources (Vita 34 AG)

Own photovoltaic system at the Leipzig site (Vita 34 AG)

91 % use of the energy generated by the PV system

Resource utilization & waste

45,132 kg of hazardous waste, which was disposed of properly (at Vita 34 AG, Seracell Pharma GmbH, PBKM, Famicord Suisse S.A., KRIO Intézet Zrt.)

Measures in terms of reuse (examples):
– Multiple use of collection boxes for the transportation of umbilical cord blood and tissue
– Storage using waste-saving metal cassettes
– Switching from anodic to non-anodic oxidized cassettes for storage to reduce energy consumption and a negative environmental impact
– Recycling of old technical equipment

Water

1,529,450 liters of water consumed (Vita 34 AG & PBKM)

Water saving measures: supply of rainwater (PBKM) and water-saving technologies for toilet flushing and water filter systems (KRIO Intézet Zrt.)
Okno dialogowe
Social

Our employees

78% women’s quota

65% women’s quota in management positions

1 satisfaction survey conducted annually

Numerous measures to promote health, including medical check-ups, health courses, accident insurance, 4-day week, cooperation with medical practices, etc.

Approx. 12 hours of training per year per employee, including individual professional and soft skills training

Patient safety

Ensuring the highest safety standards in the collection, preparation and storage of samples

Regular training of laboratory and hospital staff

Social responsibility (examples)

Family umbilical cord program

Targeted donation program for siblings of young cancer patients

Public umbilical cord blood bank

Scholarship program for young scientists “EXCELLent Grand”

Anonymous sperm donor program

Data protection & IT security

On-premise IT strategy, 3-2-1 backup concept and external help to strengthen data security
Okno dialogowe
Governance

Compliance

Introduction of Group-wide Compliance Management System (CMS)

Recruitment of Head of Legal & Compliance

Introduction of Group-wide Code of Conduct including the topics: fair competition, prevention of corruption and bribery, lobbying, data protection, environmental protection, human rights, equal opportunities, diversity, fair working conditions and social commitment

Whistleblowing

Introduction of a Group-wide whistleblowing system

Anti-corruption

Implementation of local anti-corruption training courses

Lobbying & associations

Registered in the German lobby register

Member of the ”Cord Blood Association” (CBA)

Respect for human rights

O cases of human rights violations

Expansion of efforts to combat human rights violations

Key Objectives for 2024

Professionalization of
sustainability management & development of governance structure

Developing and rolling out several ESG policies

Establishment of company-wide ESG reporting

Improvement of ESG data structures

2024/04/29

ESG Highlights 2023

104KB

Download PDF
2024/04/29

ESG Report 2023

603KB

Download PDF